Cargando…

Aging and neuroplasticity

Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, de...

Descripción completa

Detalles Bibliográficos
Autor principal: Smith, Gwenn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622467/
https://www.ncbi.nlm.nih.gov/pubmed/23576885
_version_ 1782265838689058816
author Smith, Gwenn S.
author_facet Smith, Gwenn S.
author_sort Smith, Gwenn S.
collection PubMed
description Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, dementia, and stroke and a range of interventions, including manipulations in behavior (physical and cognitive activity/exercise), physiological factors (caloric restriction, cholesterol), pharmacologic treatments (AMPA receptors) and manipulation of brain magnetic fields and electrical activity (transcranial magnetic stimulation, magnetic seizure therapy, and deep brain stimulation).This editorial will address different facets of neuroplasticity, the need for translational research to interpret neuroimaging data thought to reflect neuroplasticity in the human brain, and the next steps for testing interventions in aging and in disease.
format Online
Article
Text
id pubmed-3622467
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-36224672013-04-10 Aging and neuroplasticity Smith, Gwenn S. Dialogues Clin Neurosci Guest Editorial Neuroplasticity can be defined as a final common pathway of neurobiological processes, including structural, functional or molecular mechanisms, that result in stability or compensation for age- or disease-related changes. The papers in this issue address the aging process, as well as depression, dementia, and stroke and a range of interventions, including manipulations in behavior (physical and cognitive activity/exercise), physiological factors (caloric restriction, cholesterol), pharmacologic treatments (AMPA receptors) and manipulation of brain magnetic fields and electrical activity (transcranial magnetic stimulation, magnetic seizure therapy, and deep brain stimulation).This editorial will address different facets of neuroplasticity, the need for translational research to interpret neuroimaging data thought to reflect neuroplasticity in the human brain, and the next steps for testing interventions in aging and in disease. Les Laboratoires Servier 2013-03 /pmc/articles/PMC3622467/ /pubmed/23576885 Text en Copyright: © 2013 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Guest Editorial
Smith, Gwenn S.
Aging and neuroplasticity
title Aging and neuroplasticity
title_full Aging and neuroplasticity
title_fullStr Aging and neuroplasticity
title_full_unstemmed Aging and neuroplasticity
title_short Aging and neuroplasticity
title_sort aging and neuroplasticity
topic Guest Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622467/
https://www.ncbi.nlm.nih.gov/pubmed/23576885
work_keys_str_mv AT smithgwenns agingandneuroplasticity